YiChang HEC ChangJiang Ph... (YIHCF)

PNK: YIHCF · Real-Time Price · USD

0.55

0.00 (0.00%)

At close: May 01, 2025, 8:00 PM

YiChang HEC ChangJiang Pharmaceutical Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Revenue	2.45B	3.09B	3.21B	2.45B	1.29B	711.54M	202.25M	264.41M	2.08B	3.15B	3.07B	1.03B	1.48B	939.31M	662.25M	385.88M	555.63M
Cost of Revenue	505.53M	663.76M	645.07M	566.23M	332.65M	328.63M	101.46M	1.32M	352.86M	471.38M	450.44M	159.81M	239M	158.77M	121.64M	77.92M	136.32M
Gross Profit	1.95B	2.42B	2.56B	1.89B	960.66M	382.91M	100.79M	263.09M	1.73B	2.68B	2.62B	868.23M	1.24B	780.54M	540.61M	307.96M	419.31M
Operating Income	867.38M	956.08M	1.48B	79.61M	243.12M	37.01M	-495.11M	-75.77M	909.46M	1.23B	1.3B	340.79M	742.64M	401.99M	360.49M	151.01M	268.56M
Interest Income	n/a	62.84M	102.14M	141.07M	133.84M	121.28M	111.18M	110.12M	109.1M	90.99M	77.47M	8.96M	4.22M	12.71M	2.26M	4.98M	4.11M
Pretax Income	813.53M	864.92M	1.26B	75.82M	-36.4M	-78.98M	-588.2M	252.6M	757.84M	1.1B	1.17B	355.46M	746.86M	389.96M	358.23M	188.62M	264.44M
Net Income	684.73M	963.13M	1.03B	109.4M	-32.8M	-80.62M	-507.03M	221.95M	617.51M	950.28M	968.42M	307.99M	634.54M	345.24M	301.86M	165.61M	214.99M
Selling & General & Admin	878.8M	1.01B	927.34M	873.61M	677.43M	419.77M	463.47M	625.55M	842.01M	1.56B	1.31B	530.79M	507.25M	389.74M	175.34M	146.34M	167.26M
Research & Development	265.93M	94.02M	98.26M	88.71M	40.91M	86.99M	49.67M	64.44M	54.98M	108.88M	53.74M	116.58M	107.53M	72.88M	24.04M	38.38M	25.86M
Other Expenses	-62.87M	359.58M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	1.08B	1.47B	1.2B	1.67B	863.22M	340.61M	577.81M	97M	863.91M	1.49B	1.37B	521.73M	500.79M	403.28M	180.12M	124.32M	150.76M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	660.91M	791.65M	755.5M	683.49M	533.11M	262.74M	258.93M	467.02M	686.86M	1.24B	1.12B	320.89M	332.76M	254.13M	117.96M	70.77M	110.12M
Cost & Expenses	1.59B	2.13B	1.85B	2.23B	1.2B	669.24M	679.27M	98.31M	1.22B	1.97B	1.82B	681.55M	739.79M	562.06M	301.76M	202.24M	287.07M
Income Tax Expense	128.8M	33.02M	237.93M	5.88M	3.94M	1.77M	81.23M	31.93M	141.09M	149.4M	212.46M	65.03M	136.07M	58.88M	62.96M	23.01M	49.46M
Shares Outstanding (Basic)	879.97M	883.6M	879.97M	879.97M	819.95M	879.97M	874.19M	2.32B	980.31M	960.67M	891.19M	904.05M	904.05M	904.05M	903.57M	901.65M	901.62M
Shares Outstanding (Diluted)	879.97M	879.97M	879.97M	879.97M	879.97M	879.97M	879.97M	1.11B	1.1B	1.13B	891.19M	904.05M	904.05M	904.05M	903.57M	901.64M	901.61M
EPS (Basic)	0.78	1.09	1.17	0.12	-0.04	-0.09	-0.58	0.10	0.63	0.99	1.09	0.34	0.70	0.38	0.33	0.18	0.24
EPS (Diluted)	0.78	1.09	1.17	0.12	-0.04	-0.09	-0.58	0.20	0.56	0.84	1.09	0.34	0.70	0.38	0.33	0.18	0.24
EBITDA	9.01B	1.5B	1.66B	274.3M	417.18M	173.37M	-379.93M	-8.58M	958.82M	1.27B	1.34B	374.59M	769.93M	428.95M	377.32M	165.25M	281.77M
EBIT	818.17M	1.31B	1.47B	79.61M	243.12M	37.01M	-495.11M	-75.77M	909.46M	1.23B	1.3B	340.79M	742.64M	401.99M	360.49M	151.01M	268.56M
Depreciation & Amortization	8.19B	193.69M	188.61M	194.7M	174.06M	136.36M	115.19M	67.19M	49.35M	38.57M	43.26M	33.8M	27.29M	26.97M	16.83M	14.23M	13.21M